Scancell Holdings plc (LON:SCLP - Get Free Report)'s stock price traded up 29.8% on Monday . The stock traded as high as GBX 11.49 ($0.15) and last traded at GBX 11 ($0.15). 10,149,031 shares were traded during mid-day trading, an increase of 1,037% from the average session volume of 892,663 shares. The stock had previously closed at GBX 8.48 ($0.11).
Scancell Trading Up 5.5 %
The company has a debt-to-equity ratio of -566.79, a current ratio of 3.42 and a quick ratio of 13.01. The firm has a market capitalization of £109.27 million, a price-to-earnings ratio of -16.18 and a beta of 0.35. The business's 50 day moving average price is GBX 8.58 and its 200-day moving average price is GBX 10.80.
Scancell (LON:SCLP - Get Free Report) last issued its earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. Equities analysts forecast that Scancell Holdings plc will post -2.5361112 EPS for the current fiscal year.
About Scancell
(
Get Free Report)
Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.
Further Reading
Before you consider Scancell, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scancell wasn't on the list.
While Scancell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
